GlucoMe, a comprehensive, digital diabetes care platform that intends to streamlines the disease management process for patients, medical teams and healthcare providers, announced yesterday that it has collaborated with Switzerland-based Roche as a new partner due to its involvement in the current Startup Creasphere Batch 2 Program.
Set-up by Roche and Plug and Play to accelerate digital healthcare Startup Creasphere is the first digital health innovation hub in Europe. GlucoMe was chosen to collaborate with Roche from one of 11 companies that are participating in the global initiative, following a screening process of more than 200 health-focused start-up companies.
GlucoMe's CEO, Yiftah Ben-Aharon, said, 'We are excited to partner with Roche and Plug & Play. From some very tough competition involving world-class promising digital health start-ups, the new Roche partnership will help GlucoMe rapidly advance our digital diabetes platform to set a new standard in diabetes care delivery.'
Diamyd Medical granted US FDA Fast Track designation for Diamyd diabetes treatment
Aprecia names new chief commercial officer
Insulet's Omnipod 5 integration with Abbott FreeStyle Libre 2 Plus Sensor secures CE Mark approval
Kyowa Kirin enrols first subject in phase two tivozanib eye drops (KHK4951) clinical trial
Novo Nordisk to boost manufacturing capacity with acquisition of three fill-finish sites
Breye Therapeutics commences phase 1b/2a danegaptide clinical trial
DexCom Inc breaks ground on new manufacturing facility in Ireland
VibroSense Dynamics AB secures provisional patent for chemotherapy-induced nerve damage prediction
Innovent Biologics signs collaboration agreement with Sanegene Bio USA
Japan approves GSK's filing for Arexvy vaccination for at-risk adults
Arecor Therapeutics plc extends collaboration with Eli Lilly
OptiBiotix Health partners with Ravenswood for SlimBiome distribution in Australia and New Zealand
Boehringer Ingelheim granted European approval of oral liquid medication for feline diabetes